# The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions

> **NCT04476719** · PHASE1 · UNKNOWN · sponsor: **Atabay Kimya Sanayi Ticaret A.S.** · enrollment: 18 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** ATAFENOVIR 200 MG KAPSUL
- **DRUG:** ARBIDOL 100 MG KAPSUL

## Key facts

- **NCT ID:** NCT04476719
- **Lead sponsor:** Atabay Kimya Sanayi Ticaret A.S.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-09
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-08-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476719, "The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04476719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*